Tools and Guidelines

The monitoring tool is divided into two parts. The first part addresses epidemiological trends in mother-to-child transmission in prison, with a view to collecting the epidemiological data needed to monitor progress towards the global targets on prevention of mother-to-child transmission. The second part covers access to health care and social services needed within the prison setting in order to reach the 2025 HIV targets. Indicators in this second part include information on the availability and coverage of relevant services. Public health-care priorities as set in the UNODC technical guidance documents are taken into consideration, as is the protection of human rights, women’s rights, privacy and confidentiality.  

In this guideline, WHO recommends that long-acting injectable cabotegravir (CAB-LA) may be offered as an additional HIV prevention option for people at substantial risk of HIV infection. CAB-LA is an injectable form of pre-exposure prophylaxis (PrEP) that has been shown to be highly effective at reducing the risk of HIV acquisition. This guideline provides implementation considerations to support Member States, programme managers, policy makers, researchers, health workers, communities, and other stakeholders in the implementation of projects and programmes for CAB-LA. It also outlines critical research gaps for CAB-LA.

The Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations outline a public health response for 5 key populations (men who have sex with men, trans and gender diverse people, sex workers, people who inject drugs and people in prisons and other closed settings). They present and discuss new recommendations and consolidate a range of recommendations and guidance from current WHO guidelines. Particularly for key populations, social, legal, structural and other contextual factors both increase vulnerability to HIV, viral hepatitis and STIs and obstruct access to health and other essential services. These guidelines highlight the critical importance of addressing structural barriers in all settings as a priority.

These guidelines focus on the collection and use of person-centred data across the HIV cascade – from prevention, testing and treatment to longer-term health care – building upon 2017 and 2020 strategic information guidelines. The updated guidelines present a standard minimum dataset, priority indicators and recommendations to strengthen data use across HIV prevention, testing and treatment, and linkages to services for sexually transmitted infections, viral hepatitis, tuberculosis and cervical cancer. The guidelines also cover the use of routinely collected data for HIV surveillance (including measurement of HIV prevalence and incidence) and emphasize the use of data from different sources to gain a better picture of epidemiologic trends.

Validation of elimination of mother-to-child transmission, or vertical transmission, of HIV, syphilis and hepatitis B virus (HBV), is an attestation that a country has successfully met standard criteria for elimination, or for being at 1 of the 3 levels of achievement on the ‘Path to Elimination’ while delivering quality services for women, girls and their children, through the life-course, respecting human rights and ensuring gender equality and community engagement.  This document, the third version, adds on EMTCT of hepatitis B virus (HBV), bringing together a package of interventions and metrics to support integrated management and monitoring of vertical transmission across a wide range of epidemiological and programmatic contexts.

It cannot be stressed enough that violence against women and girls continues to be one of the most pervasive human rights violations in the world. It acts as both a cause and a consequence of gender inequality, and ranges in impact from adverse effects on the health, safety, productivity and overall well-being of women and girls, to impeding the realization of their rights and contribution to society at large. Despite decades of concerted efforts, at the global, regional and local levels.

This global progress in identification of newer drug molecules that are more robust and less toxic, a significant reduction in the cost of therapy and innovative approaches to service delivery and increasing access to treatment have literally transformed the disease from a virtual death sentence in the early 1980s to a chronic manageable disease now.

This compendium is designed to help National TB Programmes (NTPs) to make best use of the available tools for policy, planning and programmatic action. The document summarizes information about the key tools related to data and evidence that are available for use in TB planning and programming, and how they can be applied. The tools that are profiled are described in terms of how they fit within the People-centred framework for tuberculosis programme planning and prioritization. Together with the people-centred framework, this compendium aims to enable better use of data and evidence for TB programme planning at both the national and subnational levels. It is designed to help NTPs and their national stakeholders to understand how and when different data and evidence-related tools could be used.

Voluntary medical male circumcision (VMMC) has been recommended by WHO and UNAIDS since 2007, and was re-evaluated in 2020 as an effective intervention for the prevention of heterosexually acquired HIV in men in settings where the prevalence of heterosexually transmitted HIV is high, with a focus on 15 countries in sub-Saharan Africa. These countries have established and rapidly scaled up VMMC within HIV programmes, and through 2019 over 27 million VMMCs were performed. The WHO 2020 VMMC Guidelines, and previous guidance documents, had identified reaching men at higher risk of HIV as a future priority for VMMC programme and research efforts. The 2020 guidance focused first on providing an up-to-date evidence summary on methods for enhancing uptake among adult men generally.

The PLHIV Stigma Index Implementation Guidelines: A handbook to support networks of people living with HIV to conduct the PLHIV Stigma Index 2.0. The Implementation Guidelines provide step-by-step guidance on all phases of implementation and link to many helpful templates and tools that can be used throughout the process.